I JMIR出版物为癌症患者提供的数字自我管理程序(帮助有效克服问题)卡塔尔世界杯8强波胆分析:可行性随机对照试验%A Wright,Hayley %A Martin,Faith %A Clyne,Wendy %A Clark,Cain C T %A Matouskova,Gabriela %A McGillion,Michael %A Turner,Andrew %+智能医疗中心,健康与福祉研究所,考文垂大学,Priory Street, CV1 5FB,英国,44 7599782465,hsx116@coventry.ac.uk %K自我管理%K癌症%K生存率%K数字%K积极心理学%D 2021 %7 5.11.2021 %9原创论文%J J医学互联网资源%G英语%X背景:我们提出了一项1:1分配比例的可行性、随机候选对照组(CG)并行设计研究的结果。参与者被随机分为干预组(IG)和等待组(CG)。干预是一个为期6周的数字自我管理项目,帮助有效克服问题(HOPE),针对癌症患者。目的:本研究旨在测试癌症患者数字化自我管理方案的可行性。这将为确定的随机对照试验的设计提供依据。此外,通过次要结果对HOPE项目影响的初步评估将用于评估试验背景下的有效性信号。方法:参与者从Macmillan Cancer Support推荐的机会样本中抽取,通过电子邮件邀请他们参与研究(N=61)。主要结果包括招募率、保留率、随访率、完成率和依从率、样本量和效应量估计,以及确定试验的进展标准评估。 Secondary outcomes were self-report measures of participants’ positive mental well-being, depression, anxiety, and patient activation (ie, confidence in managing their cancer). The intervention and data collection took place on the web. Results: The recruitment rate was 77% (47/61). A total of 41 participants completed the baseline questionnaires and were randomized to either the IG (n=21) or the waitlist CG (n=20). The retention rate (attending all program sessions) was greater than 50% (all: 21/41, 51%, IG: 10/21, 48%; and CG: 11/20, 55%). The follow-up rate (completing all questionnaires) was greater than 80% (all: 33/41, 80%; IG: 16/21, 76%; and CG: 17/20, 85%). The completion rate (attending ≥3 sessions and completing all questionnaires) was greater than 60% (all: 25/41, 61%; IG: 13/21, 62%; and CG: 12/20, 60%). Engagement data showed that participants viewed between half (5.1/10, 51%) and three-quarters (12.2/16, 76%) of the pages in each session. Conclusions: All progression criteria for a definitive trial were met, as supported by the primary outcome data. The IG showed improved postprogram scores on measures of positive mental well-being, depression, anxiety, and patient activation. A full-scale trial of the digital HOPE program for people with cancer will allow us to fully evaluate the efficacy of the intervention relative to a CG. Trial Registration: ISRCTN Registry ISRCTN79623250; http://www.isrctn.com/ISRCTN79623250 International Registered Report Identifier (IRRID): RR2-10.2196/24264 %M 34738912 %R 10.2196/28322 %U //www.mybigtv.com/2021/11/e28322 %U https://doi.org/10.2196/28322 %U http://www.ncbi.nlm.nih.gov/pubmed/34738912
Baidu
map